ECSP088588A - Uso de sales de tiotropio en el tratamiento del asma persistente moderada - Google Patents

Uso de sales de tiotropio en el tratamiento del asma persistente moderada

Info

Publication number
ECSP088588A
ECSP088588A EC2008008588A ECSP088588A ECSP088588A EC SP088588 A ECSP088588 A EC SP088588A EC 2008008588 A EC2008008588 A EC 2008008588A EC SP088588 A ECSP088588 A EC SP088588A EC SP088588 A ECSP088588 A EC SP088588A
Authority
EC
Ecuador
Prior art keywords
treatment
salts
tiotrope
moderate asthma
persistent moderate
Prior art date
Application number
EC2008008588A
Other languages
English (en)
Inventor
Michael Engel
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088588(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of ECSP088588A publication Critical patent/ECSP088588A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al uso de sales de tiotropio para la preparación de un medicamento destinado al tratamiento de pacientes que padecen asma persistente moderada.
EC2008008588A 2006-01-04 2008-06-27 Uso de sales de tiotropio en el tratamiento del asma persistente moderada ECSP088588A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04

Publications (1)

Publication Number Publication Date
ECSP088588A true ECSP088588A (es) 2008-07-30

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008588A ECSP088588A (es) 2006-01-04 2008-06-27 Uso de sales de tiotropio en el tratamiento del asma persistente moderada

Country Status (30)

Country Link
US (2) US20070155773A1 (es)
EP (1) EP1971332B1 (es)
JP (1) JP2009525950A (es)
KR (1) KR20080083060A (es)
CN (1) CN101355937A (es)
AR (1) AR059126A1 (es)
AT (1) ATE500825T1 (es)
AU (1) AU2006334367B2 (es)
BR (1) BRPI0620886A2 (es)
CA (1) CA2634984C (es)
CY (1) CY1111534T1 (es)
DE (1) DE602006020620D1 (es)
DK (1) DK1971332T3 (es)
EA (1) EA015353B1 (es)
EC (1) ECSP088588A (es)
ES (1) ES2362306T3 (es)
HR (1) HRP20110200T1 (es)
IL (1) IL192602A (es)
ME (1) ME01205B (es)
MY (1) MY146362A (es)
NO (1) NO20082439L (es)
NZ (1) NZ570162A (es)
PL (1) PL1971332T3 (es)
PT (1) PT1971332E (es)
RS (1) RS51703B (es)
SI (1) SI1971332T1 (es)
TW (1) TW200731976A (es)
UA (1) UA95271C2 (es)
WO (1) WO2007077162A1 (es)
ZA (1) ZA200804436B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2617717C (en) 2005-08-06 2014-02-11 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
CA2425539C (en) * 2000-10-12 2007-04-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
KR101285571B1 (ko) * 2003-11-03 2013-07-15 베링거 인겔하임 인터내셔날 게엠베하 항콜린성 효과를 지닌 신규한 무수 결정
UY28590A1 (es) * 2003-11-03 2005-06-30 Boehringer Ingelheim Int Procedimiento para la preparación de nuevas sales de tiotropio, nuevas sales de tiotropio como tales, así como las formulaciones medicamentosas que las contienen.
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
AU2006244683A1 (en) * 2005-05-10 2006-11-16 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
AU2006248189A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
CA2617717C (en) * 2005-08-06 2014-02-11 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
NO20082439L (no) 2008-08-04
CN101355937A (zh) 2009-01-28
US20150224090A1 (en) 2015-08-13
KR20080083060A (ko) 2008-09-12
ATE500825T1 (de) 2011-03-15
RS51703B (sr) 2011-10-31
CA2634984C (en) 2014-05-06
EP1971332A1 (en) 2008-09-24
PL1971332T3 (pl) 2011-08-31
IL192602A0 (en) 2009-09-22
PT1971332E (pt) 2011-03-18
EP1971332B1 (en) 2011-03-09
CY1111534T1 (el) 2015-08-05
JP2009525950A (ja) 2009-07-16
EA200801629A1 (ru) 2008-12-30
WO2007077162A1 (en) 2007-07-12
AU2006334367B2 (en) 2012-11-08
UA95271C2 (ru) 2011-07-25
ME01205B (me) 2013-03-20
CA2634984A1 (en) 2007-07-12
ZA200804436B (en) 2008-12-31
MY146362A (en) 2012-08-15
DK1971332T3 (da) 2011-04-18
HRP20110200T1 (hr) 2011-04-30
ES2362306T3 (es) 2011-07-01
EA015353B1 (ru) 2011-06-30
AU2006334367A1 (en) 2007-07-12
AR059126A1 (es) 2008-03-12
TW200731976A (en) 2007-09-01
NZ570162A (en) 2011-09-30
US20070155773A1 (en) 2007-07-05
IL192602A (en) 2013-06-27
SI1971332T1 (sl) 2011-05-31
DE602006020620D1 (de) 2011-04-21
BRPI0620886A2 (pt) 2011-11-29

Similar Documents

Publication Publication Date Title
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
MX357820B (es) Composiciones para uso en la manufactura de medicamentos para tratamiento de esclerosis multiple progresiva.
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
CL2012000248A1 (es) Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina.
GT201400009A (es) 4-imidazopiridazin-1-il-benzamidas y 4-imidazotriazin-1-il-benzamidas como inhibidores de btk
CR11455A (es) Compuestos nuevos de hidrocarbono ciclico para el tratamiento de enfermedades
SV2010003581A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
AR092177A1 (es) Metodos para tratar o prevenir asma administrando un antagonista de il-4r
UY31922A (es) Compuestos
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
UY32455A (es) Derivados de aminotetralina, composiciones farmacéuticas que la contienen, y sus usos en terapia
SV2011003802A (es) Derivados de triazol utiles para el tratamiento de enfermedades
ECSP088874A (es) Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual
UY29899A1 (es) Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopausicos
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
BR112014005025A2 (pt) composição farmacêutica para uso no tratamento de uma doença neurodegenerativa
BR112014030406A2 (pt) combinação de canabidiol fitocanabinoide com hipotermia terapêutica
BR112014012459A2 (pt) 2h-indazóis como antagonistas do receptor de ep2
BRPI0911469A8 (pt) Inibidores de gm-csf e il-17 para terapia
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
UY33723A (es) ?COMPUESTOS Y SU USO PARA TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON Aß?.
ECSP088588A (es) Uso de sales de tiotropio en el tratamiento del asma persistente moderada
EA201171414A1 (ru) Ингибиторы белков семейства iap
DOP2010000400A (es) 7-sulfanilmetil-,7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos